Stamford, CT -- (SBWIRE) -- 10/05/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Dynavax Technologies Corporation (NASDAQ:DVAX), Horizon Pharma Inc (NASDAQ:HZNP), Zalicus Inc (NASDAQ:ZLCS), Companhia Siderurgica Nacional (ADR) (NYSE:SID)
Dynavax Technologies Corporation (NASDAQ:DVAX) stock is at $1.28, up +4.92 percent from its previous close of $0.36. The stock opened the session at $0.36 and touched its highest price point at $1.22. DVAX stock’s lowest price point for the session stood at $1.29.
It remained positive +20.75% during the previous three months trade.
Its total trading volume is 1.07 million shares for the day, in comparison to its average trading volume of 2.34 million shares. Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. It develops product candidates based on the use of immunostimulatory sequences and immunoregulatory sequences.
For How Long DVAX’s Gloss will Attract Investors? Find out via this report
Horizon Pharma Inc (NASDAQ:HZNP) stock is at $3.67, up +7.31 percent from its previous close of $3.42. Its today’s volume is 1.06 million shares, in comparison to its average trading volume of 713,656 shares. The stock opened the session at $3.41 and touched its highest price point at $3.70.
HZNP’s lowest price point for the session stood at $3.30 and its 52 week price range stood at $1.97 - $3.70. The company has a total of 64.49 million outstanding shares and its total market capitalization is $236.69 million. Its earnings per share was -$1.52. Horizon Pharma, Inc., a specialty pharmaceutical company, through its subsidiaries, develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases.
For How Long HZNP will fight for Profitability? Read This Trend Analysis report
Zalicus Inc (NASDAQ:ZLCS) opened the session at $6.22 and remained in the $5.31 to $6.25 price range during the session. The stock is -11.32 percent lower, at $5.64. Volume closed the day at 3.05 million shares, its average volume being 771,038 shares.
The company has a total of 22.48 million outstanding shares and its total market capitalization is $126.79 million. Its beta value stands at 2.46times and earnings per share was -$1.84.
ZLCS was a gainer in the 5 days activity and jumped about +637.45%. The one month performance of the stock was positive and it scored more than +623.08%. Zalicus Inc., a biopharmaceutical company, engages in the discovery and development of novel treatments for patients suffering from pain. The company develops Z160, a novel oral N-type calcium channel blocker that is under 2 Phase 2a clinical trials for the treatment of neuropathic pain, including post-herpetic neuralgia and lumbosacral radiculopathy; Z944.
Why Should Investors Buy ZLCS After the Recent Fall? Just Go Here and Find Out
Companhia Siderurgica Nacional (ADR) (NYSE:SID) traded in the range of $4.36 and $4.52 in its previous trading session. The stock recorded the volume of 8.98 million shares, in comparison to its average daily trading volume of 7.19 million shares.
Company’s year to date performance remained declining as it lost almost -23.73%. If we look at the last 6 months of trade, that is in the bullish zone with an increase of +1.58%. The stock opened at $4.37 and its closing price for the day was $4.50, up +3.69 percent from its previous close of $4.34. Companhia Siderúrgica Nacional operates as an integrated steel producer primarily in Brazil. The company principally produces carbon steel and various steel products for automotive, home appliance, packaging, construction, and steel processing industries. Its products include slabs.
Why Should Investors Buy SID After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)